TB Alliance

Dr. Maarten van Cleeff Elected New President of TB Alliance Stakeholders Association

Published in AIDS Weekly, January 25th, 2010

The Global Alliance for TB Drug Development (TB Alliance) announced the election of Dr. Maarten van Cleeff as President of its Stakeholders Association. Dr. van Cleeff will also serve as an Ex Officio member of the TB Alliance's Board of Directors.

The TB Alliance is a not-for-profit, product development partnership leading the discovery and development of affordable, new TB drugs that will shorten and simplify treatment, be effective against drug-resistant strains, and be compatible with antiretroviral therapies for patients coinfected with HIV. The Alliance currently manages the largest portfolio of potential new TB drugs ever assembled, including three compounds in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2010-01-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry